Tabula Rasa Healthcare to Announce First Quarter
Post# of 301275
MOORESTOWN, N.J., April 12, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC ), a disruptive innovation and technology leader in medication safety, offering a unique Medication Risk Stratification and Medication Risk Mitigation Matrix ® suite of decision support tools, will release its first quarter 2017 operating results on Monday, May 1, 2017 after market close, on the investor relations section of TRHC’s website at ir.trhc.com with a conference call hosted by TRHC’s management to follow at 5:00 p.m. EDT.
Stockholders and interested participants may listen to a live broadcast of the conference call by dialing 844-413-0947 or 216-562-0423 for international callers, and referencing participant code 3892278 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of TRHC’s website ( ir.trhc.com ) and an audio file of the call will also be archived and available for replay approximately two hours after the live event for a period of 90 days thereafter at ir.trhc.com . After the conference call, a replay will be available until May 8, 2017 and can be accessed by dialing 855-859-2056 or 404-537-3406 for international callers, and referencing participant code 3892278.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ: TRHC ) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC has focused on optimizing outcomes for PACE and other healthcare organizations through its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools. For more information, please visit: www.TRHC.com .
Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 tabularasa@westwicke.com Media Dianne Semingson dsemingson@TRHC.com 215-870-0829
(0)
(0)